Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country
Aim To retrospectively report the clinical outcomes of non-Hodgkin's Lymphoma (NHL) patients post high dose therapy (HDT) with autologous haematopoietic stem cell transplant (AHSCT) and determine whether upfront transplant, which is a first-line consolidative treatment with induction chemothera...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Published: |
Blackwell Publishing
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/28862/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.28862 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.288622022-04-21T07:13:40Z http://eprints.um.edu.my/28862/ Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country Anuar, Nur Adila Tey, Kevin Wen Fei Ng, Soo Chin Teh, Alan Kee Hean Abdul Rahman, Mohd Haris Fadzillah Chong, Bee Ping Gan, Gin Gin RM Therapeutics. Pharmacology RS Pharmacy and materia medica Aim To retrospectively report the clinical outcomes of non-Hodgkin's Lymphoma (NHL) patients post high dose therapy (HDT) with autologous haematopoietic stem cell transplant (AHSCT) and determine whether upfront transplant, which is a first-line consolidative treatment with induction chemotherapy, would be a feasible modality in a resource-limited country. Methods The medical records for NHL patients who had undergone HDT followed by AHSCT from October 1997 to November 2016 from two hospitals in Klang Valley, Malaysia were obtained from the medical record database and analysed retrospectively through statistical analysis. Results A total of 148 patients were retrospectively identified post-AHSCT, where the majority of whom had B cell lymphoma (53.4%). Majority of patients (88.5%) were in complete remission before AHSCT. The overall survival (OS) and event-free survival (EFS) at 3 years were 68.9% and 60.8%, respectively. The major cause of death was disease progression at 73.9%, while transplant-related mortality was 15.2%, with a median follow-up period of 179.5 weeks. Conclusion Our study illustrates the promising outcomes of HDT with AHSCT in NHL patients in a resource-limited country. We recommend larger studies to be conducted in the future with a longer duration of follow-up to validate our findings. Blackwell Publishing 2021-03 Article PeerReviewed Anuar, Nur Adila and Tey, Kevin Wen Fei and Ng, Soo Chin and Teh, Alan Kee Hean and Abdul Rahman, Mohd Haris Fadzillah and Chong, Bee Ping and Gan, Gin Gin (2021) Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country. International Journal of Clinical Practice, 75 (3). ISSN 1368-5031, DOI https://doi.org/10.1111/ijcp.13823 <https://doi.org/10.1111/ijcp.13823>. 10.1111/ijcp.13823 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
RM Therapeutics. Pharmacology RS Pharmacy and materia medica |
spellingShingle |
RM Therapeutics. Pharmacology RS Pharmacy and materia medica Anuar, Nur Adila Tey, Kevin Wen Fei Ng, Soo Chin Teh, Alan Kee Hean Abdul Rahman, Mohd Haris Fadzillah Chong, Bee Ping Gan, Gin Gin Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country |
description |
Aim To retrospectively report the clinical outcomes of non-Hodgkin's Lymphoma (NHL) patients post high dose therapy (HDT) with autologous haematopoietic stem cell transplant (AHSCT) and determine whether upfront transplant, which is a first-line consolidative treatment with induction chemotherapy, would be a feasible modality in a resource-limited country. Methods The medical records for NHL patients who had undergone HDT followed by AHSCT from October 1997 to November 2016 from two hospitals in Klang Valley, Malaysia were obtained from the medical record database and analysed retrospectively through statistical analysis. Results A total of 148 patients were retrospectively identified post-AHSCT, where the majority of whom had B cell lymphoma (53.4%). Majority of patients (88.5%) were in complete remission before AHSCT. The overall survival (OS) and event-free survival (EFS) at 3 years were 68.9% and 60.8%, respectively. The major cause of death was disease progression at 73.9%, while transplant-related mortality was 15.2%, with a median follow-up period of 179.5 weeks. Conclusion Our study illustrates the promising outcomes of HDT with AHSCT in NHL patients in a resource-limited country. We recommend larger studies to be conducted in the future with a longer duration of follow-up to validate our findings. |
format |
Article |
author |
Anuar, Nur Adila Tey, Kevin Wen Fei Ng, Soo Chin Teh, Alan Kee Hean Abdul Rahman, Mohd Haris Fadzillah Chong, Bee Ping Gan, Gin Gin |
author_facet |
Anuar, Nur Adila Tey, Kevin Wen Fei Ng, Soo Chin Teh, Alan Kee Hean Abdul Rahman, Mohd Haris Fadzillah Chong, Bee Ping Gan, Gin Gin |
author_sort |
Anuar, Nur Adila |
title |
Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country |
title_short |
Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country |
title_full |
Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country |
title_fullStr |
Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country |
title_full_unstemmed |
Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country |
title_sort |
outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: a retrospective analysis in a resource-limited country |
publisher |
Blackwell Publishing |
publishDate |
2021 |
url |
http://eprints.um.edu.my/28862/ |
_version_ |
1735409581058686976 |
score |
13.15806 |